Insider Trading March 16, 2026

Serve Robotics CSO Sells $35,027 in Shares to Cover RSU Tax Bill

Chief Software & Data Officer Anthony Armenta offloads a small stake as company posts stronger-than-expected 2025 revenue and raises 2026 guidance

By Nina Shah SERV
Serve Robotics CSO Sells $35,027 in Shares to Cover RSU Tax Bill
SERV

Anthony Armenta, Serve Robotics Inc.'s Chief Software & Data Officer, sold 3,567 shares on March 13, 2026, at $9.82 per share for $35,027 to satisfy tax obligations tied to restricted stock units. The company reported a sharp revenue increase in Q4 2025 and lifted its 2026 outlook, while analysts raised price targets and maintained favorable ratings.

Key Points

  • Anthony Armenta sold 3,567 shares at $9.82 on March 13, 2026, totaling $35,027 to cover tax obligations from vested RSUs.
  • Post-sale, Armenta directly holds 540,919 shares in Serve Robotics.
  • Serve Robotics reported Q4 2025 revenue of $0.9 million (400% y/y) and full-year 2025 revenue of $2.7 million, above prior guidance; EPS was -$0.34; analysts raised targets and the company raised 2026 guidance.

Anthony Armenta, who serves as Chief Software & Data Officer at Serve Robotics Inc. (NASDAQ:SERV), executed a sale of 3,567 common shares on March 13, 2026. The shares traded at $9.82 apiece, producing a gross transaction value of $35,027.

Following the disposition, Armenta retains direct ownership of 540,919 shares of Serve Robotics. Company disclosures indicate the sale was undertaken to satisfy tax liabilities that arose upon the vesting of restricted stock units.


In separate corporate updates, Serve Robotics reported a notable revenue acceleration in the fourth quarter of 2025, with quarterly revenue of $0.9 million, representing a 400% increase year-over-year. For the full year 2025, the company recorded $2.7 million in revenue, which exceeded its prior guidance of $2.5 million.

Despite posting a negative earnings per share figure of -$0.34, the market response was constructive. Following the results, Freedom Capital Markets raised its price target on Serve Robotics to $18 from $16 and kept a Buy rating in place. Oppenheimer reiterated an Outperform rating with a $20 price target, citing improvements in bot utilization and the integration of Diligent Robotics as supportive factors.

Serve Robotics also increased its guidance for 2026, signaling management confidence in continued revenue growth into the new year. The combination of stronger-than-anticipated top-line results and analyst optimism underpinned the reception of the company's recent announcements.


Below are key takeaways and considerations drawn from the filings and corporate updates:

  • Insider transaction: A small, targeted sale by a senior executive to address tax obligations tied to vested restricted stock units.
  • Operational momentum: Rapid revenue growth in Q4 2025 and full-year revenue that outpaced guidance.
  • Analyst reaction: Price target increases and reiterated favorable ratings from two brokerages, linked to improved bot utilization and integration efforts.

Where available, the facts above are taken directly from company disclosures and analyst commentary provided with the financial results.

Risks

  • The insider sale was executed to cover taxes on RSU vesting - an operationally neutral motivation but one that represents insider liquidity events impacting the stock - impacts corporate governance and investors in capital markets.
  • Despite revenue growth, the company reported a negative EPS of -$0.34, indicating continued profitability challenges - impacts equity investors and financial performance assessment.
  • Analyst views remain favorable but are contingent on operational improvements such as bot utilization and the integration of Diligent Robotics; failure to sustain these improvements could affect future sentiment - impacts robotics and automation sector investors.

More from Insider Trading

Marvell Technology President Sells $1.1M in Stock as Shares Trade Near Yearly High Apr 6, 2026 Edward Lampert Sells $58.5 Million in Lands’ End Stock; Company Posts Q4 Shortfall, Announces $100M Buyback Program Apr 6, 2026 NeonC/NeOnc President Buys $153,398 in Stock as Company Advances Financing and Clinical Timeline Apr 6, 2026 Edwards Lifesciences Executive Executes Option Exercise, Sells 1,019 Shares Apr 6, 2026 Penumbra Director Executes $32,822 Stock Sale Amid Deal and Upbeat Quarterly Results Apr 6, 2026